These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 32217854)
1. Outcomes and the Role of Primary Histology Following LINAC-based Stereotactic Radiation for Sarcoma Brain Metastases. Sim AJ; Ahmed KA; Keller A; Figura NB; Oliver DE; Sarangkasiri S; Robinson TJ; Johnstone PAS; Yu HM; Naghavi AO Am J Clin Oncol; 2020 May; 43(5):356-361. PubMed ID: 32217854 [TBL] [Abstract][Full Text] [Related]
2. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases. Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482 [TBL] [Abstract][Full Text] [Related]
6. Single-dose versus fractionated stereotactic radiotherapy for brain metastases. Kim YJ; Cho KH; Kim JY; Lim YK; Min HS; Lee SH; Kim HJ; Gwak HS; Yoo H; Lee SH Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):483-9. PubMed ID: 20800386 [TBL] [Abstract][Full Text] [Related]
7. Stereotactic radiosurgery of brain metastases: a retrospective study. Gruber I; Weidner K; Treutwein M; Koelbl O Radiat Oncol; 2023 Dec; 18(1):202. PubMed ID: 38115009 [TBL] [Abstract][Full Text] [Related]
8. Stereotactic radiosurgery for sarcoma metastases to the brain: a single-institution experience. Zamarud A; Park DJ; Dadey DYA; Yoo KH; Marianayagam NJ; Yener U; Szalkowski GA; Pollom E; Soltys S; Chang SD; Meola A Neurosurg Focus; 2023 Aug; 55(2):E7. PubMed ID: 37527671 [TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes of gastrointestinal brain metastases treated with radiotherapy. Sanghvi SM; Lischalk JW; Cai L; Collins S; Nair M; Collins B; Unger K Radiat Oncol; 2017 Feb; 12(1):43. PubMed ID: 28245881 [TBL] [Abstract][Full Text] [Related]
10. Stereotactic radiosurgery for intracranial hemangiopericytomas: a multicenter study. Cohen-Inbar O; Lee CC; Mousavi SH; Kano H; Mathieu D; Meola A; Nakaji P; Honea N; Johnson M; Abbassy M; Mohammadi AM; Silva D; Yang HC; Grills I; Kondziolka D; Barnett GH; Lunsford LD; Sheehan J J Neurosurg; 2017 Mar; 126(3):744-754. PubMed ID: 27104850 [TBL] [Abstract][Full Text] [Related]
11. Survival after surgery and stereotactic radiosurgery for patients with multiple intracranial metastases: results of a single-center retrospective study. Smith TR; Lall RR; Lall RR; Abecassis IJ; Arnaout OM; Marymont MH; Swanson KR; Chandler JP J Neurosurg; 2014 Oct; 121(4):839-45. PubMed ID: 24857242 [TBL] [Abstract][Full Text] [Related]
12. Reirradiation of metastases of the central nervous system: part 1-brain metastasis. Rades D; Simone CB; Wong HCY; Chow E; Lee SF; Johnstone PAS Ann Palliat Med; 2024 Jul; 13(4):1133-1140. PubMed ID: 38509654 [TBL] [Abstract][Full Text] [Related]
13. Outcomes and toxicity for hypofractionated and single-fraction image-guided stereotactic radiosurgery for sarcomas metastasizing to the spine. Folkert MR; Bilsky MH; Tom AK; Oh JH; Alektiar KM; Laufer I; Tap WD; Yamada Y Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1085-91. PubMed ID: 24661662 [TBL] [Abstract][Full Text] [Related]
14. Radiosurgery in the management of brain metastasis: a retrospective single-center study comparing Gamma Knife and LINAC treatment. Tuleasca C; Negretti L; Faouzi M; Magaddino V; Gevaert T; von Elm E; Levivier M J Neurosurg; 2018 Feb; 128(2):352-361. PubMed ID: 28338441 [TBL] [Abstract][Full Text] [Related]
15. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors. Sneed PK; Mendez J; Vemer-van den Hoek JG; Seymour ZA; Ma L; Molinaro AM; Fogh SE; Nakamura JL; McDermott MW J Neurosurg; 2015 Aug; 123(2):373-86. PubMed ID: 25978710 [TBL] [Abstract][Full Text] [Related]
16. Radiosurgery or Fractionated Stereotactic Radiotherapy plus Whole-brain Radioherapy in Brain Oligometastases: A Long-term Analysis. Balducci M; Autorino R; Chiesa S; Mattiucci G; Pompucci A; Azario L; D'Agostino GR; Ferro M; Fiorentino A; Fersino S; Mazzarella C; Colosimo C; Frascino V; Anile C; Valentini V Anticancer Res; 2015 May; 35(5):3055-9. PubMed ID: 25964595 [TBL] [Abstract][Full Text] [Related]
17. Image-Guided, Linac-Based, Surgical Cavity-Hypofractionated Stereotactic Radiotherapy in 5 Daily Fractions for Brain Metastases. Soliman H; Myrehaug S; Tseng CL; Ruschin M; Hashmi A; Mainprize T; Spears J; Das S; Yang V; da Costa L; Maralani P; Heyn C; Atenafu EG; Sahgal A Neurosurgery; 2019 Nov; 85(5):E860-E869. PubMed ID: 31173150 [TBL] [Abstract][Full Text] [Related]
18. The RSSearchâ„¢ Registry: patterns of care and outcomes research on patients treated with stereotactic radiosurgery and stereotactic body radiotherapy. Davis JN; Medbery C; Sharma S; Danish A; Mahadevan A Radiat Oncol; 2013 Nov; 8():275. PubMed ID: 24274599 [TBL] [Abstract][Full Text] [Related]
19. Stereotactic radiosurgery and fractionated stereotactic radiotherapy: comparison of efficacy and toxicity in 260 patients with brain metastases. Fokas E; Henzel M; Surber G; Kleinert G; Hamm K; Engenhart-Cabillic R J Neurooncol; 2012 Aug; 109(1):91-8. PubMed ID: 22528795 [TBL] [Abstract][Full Text] [Related]
20. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis. Ojerholm E; Lee JY; Thawani JP; Miller D; O'Rourke DM; Dorsey JF; Geiger GA; Nagda S; Kolker JD; Lustig RA; Alonso-Basanta M J Neurosurg; 2014 Dec; 121 Suppl():75-83. PubMed ID: 25434940 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]